Summit Therapeutics to Present at Goldman Sachs Global Healthcare Conference
Summit Therapeutics to Participate in the 47th Annual Goldman Sachs Global Healthcare Conference

Image: Businesswire
Summit Therapeutics Inc. will present at the 47th Annual Goldman Sachs Global Healthcare Conference in Miami, Florida, on June 8, 2026. The management team will discuss the company's recent developments, including the investigational bispecific antibody, ivonescimab. The presentation will be available live on their website.
- 01Summit Therapeutics will participate in the Goldman Sachs Global Healthcare Conference on June 8, 2026.
- 02The presentation will feature a corporate overview and updates on ivonescimab, an investigational bispecific antibody.
- 03The event will take place at 10:00 AM ET in Miami, Florida.
- 04Summit Therapeutics is focused on developing therapies that address unmet medical needs.
- 05The company is headquartered in Miami, Florida, with additional offices in multiple locations including Palo Alto and Dublin.
Advertisement
In-Article Ad
Summit Therapeutics Inc. (NASDAQ: SMMT) has announced its participation in the 47th Annual Goldman Sachs Global Healthcare Conference, scheduled for June 8, 2026, in Miami, Florida. The company’s management team will conduct a fireside chat presentation at 10:00 AM ET, where they will provide an overview of the company and updates on their investigational bispecific antibody, ivonescimab. This presentation aims to inform stakeholders about Summit's recent progress and strategic initiatives. Attendees can access the presentation live on Summit's website, with an archived version available afterward. Founded in 2003, Summit Therapeutics is a biopharmaceutical company dedicated to discovering and developing therapies that enhance the quality of life and address serious unmet medical needs. The company is headquartered in Miami, with additional offices in Palo Alto, California; Princeton, New Jersey; Dublin, Ireland; and Oxford, UK. Summit emphasizes that any forward-looking statements regarding its future plans and prospects are subject to various risks and uncertainties.
Advertisement
In-Article Ad
The participation in the conference may enhance Summit Therapeutics' visibility and attract potential investors.
Advertisement
In-Article Ad
Reader Poll
What do you think about the potential of ivonescimab?
Connecting to poll...
More about Summit Therapeutics Inc.
Read the original article
Visit the source for the complete story.





